From: Fauci, Anthony (NIH/NIAID) [E]

Sent: Fri, 24 Apr 2020 10:33:49 +0000

To: Holland, Steven (NIH/NIAID) [E]

Cc: Marston, Hilary (NIH/NIAID) [E];Lerner, Andrea (NIH/NIAID) [E]
Subject: RE: Successful Submission of a Manuscript to Science (abc4208)
Thanks, Steve.

-----Original Message-----

From: Holland, Steven (NIH/NIAID) [E]E OF

Sent: Thursday, April 23, 2020 11:48 PM

To: Fauci, Anthony (NIH/NIAID) (EJ OF

Cc: Marston, Hilary (NIH/NIAID) [FE] @) @>; Lerner, Andrea (NIH/NIAID) [E]

Subject: FW: Successful Submission of a Manuscript to Science (abc4208)

This is the acalabrutinib paper today submitted to Science. NEJM was interested but wanted a month delay to be
sure about the results but some of the authors (Not the NIAID one) balked and have gone elsewhere. Just keeping
you in the loop.

Steve

Director, Division of Intramural Research National Institute of Allergy and Infectious Diseases National Institutes of
Health
Bldg. 10/11N248 MSC 1960
Bethesda, MD 20892-1960
voice
301-480-4507 fax
SE (2 (2)

Assistant lab: Eva Portillo

 

Assistant to SD: Beth Schmidt
[ ‘&) 6] voice
On 4/23/20, 1:59 PM, "Lionakis, Michail (NIII/NIAID) [E]" E20) (6) > wrote:

Attached the submitted paper, which wil! be deposited to MedRxiv.org today I think.
Mihalis
On 4/23/20, 1:34 PM, "science_editors@aaas.org" <science_editors@aaas.org> wrote:
Manuscript Title: Inhibition of Bruton Tyrosine Kinase in Patients with Severe Covid-19
Author: Lionakis
Manuscript Number: abc4208
Dear Dr. Lionakis:

You are listed as a coauthor on the above manuscript, which has recently been submitted to Science.
